Topic 368: treatment optimization by combined a-emitter (arpt)/radiotherapy (XRT) dosimetry for prostate cancer patients
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91019C00040
- Awardee
-
Radiopharmaceutical Imaging And Dosimetry, LLC UEI CM3LK9281JS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,796
Award facts
- Contract value 100% obligated
- $1,999,796.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21231, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,999,796 |
About this award
This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Radiopharmaceutical Imaging And Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The $1,999,796.00 contract is for treatment optimization services by combining alpha-emitter therapy (ARPT) and radiotherapy (XRT) dosimetry for prostate cancer patients. Radiopharmaceutical Imaging And Dosimetry has provided similar services for metastatic liver cancer patients and has partnered as a subcontractor on NIH-funded projects related to targeted alpha-emitter imaging and combination radiopharmaceutical and external beam radiotherapy.
Quick answers
Who was awarded contract 75N91019C00040?
75N91019C00040 was awarded to Radiopharmaceutical Imaging And Dosimetry, LLC by National Cancer Institute (National Institutes of Health) on September 9, 2019.
How much is contract 75N91019C00040 worth?
The government has obligated $1,999,796 on 75N91019C00040.
Was contract 75N91019C00040 competed?
The extent of competition for 75N91019C00040 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award